Cytotoxic T Cells in PD-L1–Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive Factors-Reference-Cited by-同舟云学术

Cytotoxic T Cells in PD-L1–Positive Malignant Pleural Mesotheliomas Are Counterbalanced by Distinct Immunosuppressive Factors

Published:2016-11-14 Issue:12 Volume:4 Page:1038-1048
ISSN:2326-6066
Container-title:Cancer Immunology Research
language:en
Short-container-title:Cancer Immunol Res

Author:

Awad Mark M.,Jones Robert E.,Liu Hongye,Lizotte Patrick H.,Ivanova Elena V.,Kulkarni Meghana,Herter-Sprie Grit S.,Liao Xiaoyun,Santos Abigail A.,Bittinger Mark A.,Keogh Lauren,Koyama Shohei,Almonte Christina,English Jessie M.,Barlow Julianne,Richards William G.,Barbie David A.,Bass Adam J.,Rodig Scott J.,Hodi F. Stephen,Wucherpfennig Kai W.,Jänne Pasi A.,Sholl Lynette M.,Hammerman Peter S.,Wong Kwok-Kin,Bueno Raphael

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Immunology

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A digital microfluidic device integrated with electrochemical sensor and 3D matrix for detecting soluble PD-L1;Biosensors and Bioelectronics: X;2024-08

2. Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream;Frontiers in Immunology;2024-01-08

3. Clinicopathological and prognostic significance of PD-L1 and TIM-3 expression in medullary thyroid carcinoma: a retrospective immunohistochemistry study;Journal of Endocrinological Investigation;2023-07-18

4. Unraveling tumor microenvironment heterogeneity in malignant pleural mesothelioma identifies biologically distinct immune subtypes enabling prognosis determination;Frontiers in Oncology;2022-09-27

5. Immunotherapy approaches for malignant pleural mesothelioma;Nature Reviews Clinical Oncology;2022-07-01